4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001181431-07-033816
CEO sold 35,000 shares at an average $12.89 ($451,236)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hacksell Uli CEO | 2007-05-16 | Sale | −12,901 | $12.85 | $165,778 | 110,015 | I: show line 1 in the form |
| Hacksell Uli CEO | 2007-05-16 | Sale | −10,000 | $12.90 | $129,000 | 100,015 | I: show line 2 in the form |
| Hacksell Uli CEO | 2007-05-16 | Sale | −8,499 | $12.95 | $110,062 | 91,516 | I: show line 3 in the form |
| Hacksell Uli CEO | 2007-05-16 | Sale | −1,500 | $12.87 | $19,305 | 90,016 | I: show line 4 in the form |
| Hacksell Uli CEO | 2007-05-16 | Sale | −1,300 | $12.86 | $16,715 | 88,716 | I: show line 5 in the form |
| Hacksell Uli CEO | 2007-05-16 | Sale | −800 | $12.97 | $10,376 | 87,916 | I: show line 6 in the form |
| Open-market sales · 35,000 sh · avg $12.89 · $451,236 | |||||||
Loading xslF345X02/rrd159081.xml…